Aug
10
The use of oral ketamine in the mentally retarded patient is not new. Previous clinical reports have attested to its safety and effectiveness. Theoretical considerations for deciding on the appropriate dose have been described by Grant et al. A We doubt that the relative ease of this man’s anaesthetic course could have been successfully duplicated with another agent.
The concern about secretions both oral and endobronchial is important. One previous report describes excessive salivation during emergence as a problem in a child given
a higher dose of oral ketamine.

no comment untill now